ClinicalTrials.gg
CompletedNCT06061198VRanxietyUpdated Sep 29, 2023

Impact of Virtual Reality on Patient's Anxiety Who Underwent Surgery Uner Regional Anesthesia

An interventional study of a virtual reality device in Anxiety and Satisfaction, Patient, sponsored by University Hospital, Mahdia. Completed at 1 site in Tunisia. Open to participants aged 18 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-09-29.

Primary conditionPatient SatisfactionRegistry: Anxiety DisordersReclassifiedWhy we changed it
Registry
Anxiety Disorders — the first condition term the registry derived for this study.
ClinicalTrials.gg
Patient Satisfaction
Why
  1. The registry often attaches Anxiety Disorders to studies about something else, and this study's title and listed conditions do not name it.
  2. The study's listed conditions name Patient Satisfaction.
Confidence
High: the new condition is named in the study's own listed conditions. Of 351 hand-checked studies reclassified this way, 68% were exactly right and 84% in the right disease family; the registry's first term was right for 5% (measured 2026-10-21). How we classify →
Wrong?
Tell us the study's main condition →

Sponsored by University Hospital, Mahdia · Not applicable, Interventional, and Supportive care

From the registry’s dates

  • Registered 5 months after the study started (first participant enrolled Mar 2023, registered Aug 2023).
Phase
Not applicable
Study type
Interventional
Enrollment
68
Allocation
Randomized
Ages
18 Years to 65 Years
Sex
All
01

Study summary

this study was conducted in TAHER SFAR Hospital . it included 68 patients and it aims to evaluate the impact of virtual reality on patients undergoing upper limb surgery under regional anesthesia and evaluate the consumption of hypnotics during surgery , anxiety levels and patients satisfaction. this study contain 2 arms , each arm contain 34 patients . first arm received regional anesthesia and surgery under virtual reality using a VR gear . second arm received standard care

Read the detailed description

patients who had surgery with the virtual reality experience or the VR- group ( group of patients who had surgery with standard measures without virtual reality) The patient was setup comfortably on the operating table.The echo-guided regional anesthesia appropriate to the surgical procedure is performed by an experienced anesthesiologist.In the RV+ patients, loco regional anesthesia was performed before installing the VR mask and before initiating immersing in the virtual reality space. anesthesia protocol was performed before initiating VR experience to maintain audiovisual and cognitive contact with the patient and detect possible complications For the virtual reality immersion for the VR+ group, we used an OCULUS SAMSUNG GEAR VR, a virtual reality headset connected to a SAMSUNG S7 Edge phone with headphones.The headset was worn after the loco regional anesthesia and removed at the end of the procedure.The helmet is adapted to each patient according to his head circumference measurements and the image adjustment is personalized.The VR session consists of an immersion in a natural relaxation environment produced by an application downloaded from the OCULUS STORE: VR Guided Meditation.The application offers a choice of 4 environments: Relaxing day on a tropical beach, beautiful sunset beach, mountain sunrise, or forest nap experiences . The choice of the environment is randomized according to the patient's preferences.For patients who belongs to the VR- group, the procedure was performed under standard conditions with a drape separating the patient from the operating site During surgery, the vital signs: HR, PANI, SpO2 were collected at the different peri-operative moments respectively at the entrance to the operating room (T0), 15 minutes after ALR (T1), 30 minutes after ALR (T2), 30 minutes (T3), 1 hour (T4) and 2 hours (T5) An intraoperative assessment of anxiety was performed after 15 minutes of ALR, i.e. at T1 by the LIKERT scale The anesthesist could administer anxiolytics outside of the contraindications. The molecule of choice is Midazolam and the dose taken is noted on the data collection form The administration of anxiolytics (Midazolam) is judged by clinical criteria determined in the protocol:- Anxiety during the operation judged as painful or important (higher than2 on the LIKERT scale) The session can be interrupted during the procedure for medical reasons or at the patient's request.If the local anesthesia fails and the patient is converted to general anesthesia, the protocol is cancelled and a standard induction is performed by the anesthesiologist.The events of desaturation (SpO2 \< 90%), apnea, administration of anxiolytics administration of anxiolytics (to reach a minimal level of anxiety) were indicated on the data collection form.For both RV+ and RV- groups, postoperative anxiety was assessed using the scores:1- Postoperative STAI at H1 postoperative2- patient satisfaction evaluated by a LIKERT scale

02

Conditions studied

  • Anxiety
  • Satisfaction, Patient

Browse trials for

Keywords

  • virtual reality
  • anxiety
  • patient satisfaction
03

In context

Patient Satisfaction Reclassified

877 studies on the registry are indexed under Patient Satisfaction; 202 are open to participants now.

This study's enrollment of 68 is below the median of 96 across 624 interventional studies indexed under Patient Satisfaction.

Browse Patient Satisfaction studies →

Lead sponsor

University Hospital, Mahdia is the lead sponsor of 10 studies on the registry; none are open to participants now.

Compared within Patient Satisfaction, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Anxiety Disorders. The counts are of registry records indexed under each term, refreshed daily. How we classify →

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • patient classified ASA 1 , 2 or 3
  • patients undergoing an upper-limb surgery under regional anesthesia

Exclusion criteria

Exclusion Criteria:

  • regional anesthesia failure
  • local anesthetics intoxications
  • symptoms of cyber-sickness
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
68 participants (actual)

Study arms

  • Active comparator
    group of patients who underwent surgery with the virtual reality experience

    patients underwent surgery wearing a virtual reality mask

    Device: a virtual reality device

  • No intervention
    patients who underwent surgery in standard conditions without the virtual reality experience

    patients underwent surgery without a virtual reality mask

Interventions

  • Devicea virtual reality device

    the patient will wear a masque tht will provide a virtual reality experience using a VR Gear connected to a mobile phone through an application installed on the mobile phone

06

What researchers measure

Primary outcomes

  1. hypnovel consumption during surgery

    the required dose of Midazolam for a LIKERT intraoperative anxiety score goal \< 2

    Time frame: From enrollment to the end of treatment at 10 weeks

Secondary outcomes

  1. satisfaction level during surgery

    satisfaction levels measured with a LIKERT scale : 1 : not satisfied , 2: low satisfaction , 3:satisfied , 4: great satisfaction

    Time frame: at the end of the procedure

  2. pre-operative patients's anxiety level by LIKERT score

    pre operative anxiety measured with a LIKERT scale : 1= no anxiety , 2: tolerable anxiety , 3= anxious ; 4= hard experience

    Time frame: From enrollment to the end of treatment at 10 weeks

  3. per-operative patients's anxiety level by LIKERT score

    per operative anxiety measured with a LIKERT scale : 1= no anxiety , 2: tolerable anxiety , 3= anxious ; 4= hard experience

    Time frame: From enrollment to the end of treatment at 10 weeks

  4. post-operative patients's anxiety level by LIKERT score

    post operative anxiety measured with a LIKERT scale: 1= no anxiety , 2: tolerable anxiety , 3= anxious ; 4= hard experience

    Time frame: From enrollment to the end of treatment at 10 weeks

  5. vitals : systolic pressure

    vitals were monitored all long the procedure

    Time frame: From enrollment to the end of treatment at 10 weeks

  6. vitals : heart rate

    vitals were monitored all long the procedure

    Time frame: From enrollment to the end of treatment at 10 weeks

  7. vitals : oxygen saturation

    vitals were monitored all long the procedure

    Time frame: From enrollment to the end of treatment at 10 weeks

  8. pre-operative patients's anxiety level by STAI-6 score

    pre operative anxiety measured with a STAI-6 modified scale : a total score superior to 65 : high anxiety , score between 56-65 : too high anxiety , score between : 36 - 45 : low anxiety , score inferior to 35 no anxiety

    Time frame: From enrollment to the end of treatment at 10 weeks

  9. post-operative patients's anxiety level by STAI-6 score

    post operative anxiety measured with a STAI-6 modified scale : a total score superior to 65 : high anxiety , score between 56-65 : too high anxiety , score between : 36 - 45 : low anxiety , score inferior to 35 no anxiety

    Time frame: From enrollment to the end of treatment at 10 weeks

07

Study locations

1 site
  • Taher Sfar University Hospital
    Mahdia, 5111, Tunisia
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 29, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06061198
Lead sponsor
University Hospital, Mahdia
Responsible party
Majdoub Ali MD (medical professor, University Hospital, Mahdia) — Principal investigator
First posted
Sep 29, 2023
Start date
Mar 1, 2023
Primary completion
May 18, 2023
Completion
May 18, 2023
Last update
Sep 29, 2023

Study contacts

Majdoub Ali MD, professor
principal investigator · University Hospital, Mahdia

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion